| Literature DB >> 12529364 |
Lucia Cilenti1, Younghee Lee, Sibylle Hess, Srinivasa Srinivasula, Kwon Moo Park, Daniela Junqueira, Hedvika Davis, Joseph V Bonventre, Emad S Alnemri, Antonis S Zervos.
Abstract
Omi/HtrA2 is a mammalian serine protease with high homology to bacterial HtrA chaperones. Omi/HtrA2 is localized in mitochondria and is released to the cytoplasm in response to apoptotic stimuli. Omi/HtrA2 induces cell death in a caspase-dependent manner by interacting with the inhibitor of apoptosis protein as well as in a caspase-independent manner that relies on its protease activity. We describe the identification and characterization of a novel compound as a specific inhibitor of the proteolytic activity of Omi/HtrA2. This compound (ucf-101) was isolated in a high throughput screening of a combinatorial library using bacterially made Omi-(134-458) protease and fluorescein-casein as a generic substrate. ucf-101 showed specific activity against Omi/HtrA2 and very little activity against various other serine proteases. This compound has a natural fluorescence that was used to monitor its ability to enter mammalian cells. ucf-101, when tested in caspase-9 (-/-) null fibroblasts, was found to inhibit Omi/HtrA2-induced cell death.Entities:
Mesh:
Substances:
Year: 2003 PMID: 12529364 DOI: 10.1074/jbc.M212819200
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157